| Migraine | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0003 events3 affected287 at risk
- EG0011 events1 affected46 at risk
|
| COVID 19 | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG00015 events15 affected287 at risk
- EG0011 events1 affected46 at risk
|
| Hypertension | Vascular disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0000 events0 affected287 at risk
- EG0011 events1 affected46 at risk
|
| Influenza | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0011 events1 affected46 at risk
|
| Coronary Artery Occlusion | Cardiac disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0000 events0 affected287 at risk
- EG0011 events1 affected46 at risk
|
| Anxiety | Psychiatric disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0000 events0 affected287 at risk
- EG0011 events1 affected46 at risk
|
| Headache | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG00030 events30 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Pneumonia | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Squamous Cell Carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Otitis Media | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0008 events5 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Hordeolum | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0003 events3 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0006 events6 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Diabetes | Metabolism and nutrition disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Bipolar Disorder II | Psychiatric disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| COVID 19 Vaccine reaction | Immune system disorders | MedDRA (23.0) | Non-systematic Assessment | fever, body ache, rash, swelling, migraine, chills, headache | - EG00011 events4 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Tooth fracture | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Stomachache | Gastrointestinal disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Seasonal Allergy | Immune system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Upper Respiratory Infection | Immune system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Ear infection | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Bronchitis | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Herniated disk | Musculoskeletal and connective tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Spontaneous Breast Implant Rupture | Product Issues | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| ADHD | Psychiatric disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Sinusitis | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0003 events3 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Varicose vein | Vascular disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| eczema | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Glucose Tolerance Impaired | Metabolism and nutrition disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Pyrexia | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0006 events5 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Hypercholesterolemia | Metabolism and nutrition disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0005 events5 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Dizziness | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Epistaxis | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Endometriosis | Reproductive system and breast disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Dysplastic naevus | Eye disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| acne | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| polycystic ovary syndrome | Reproductive system and breast disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Sciatica | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Lupus erythematosus | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0003 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Diarrhea | Gastrointestinal disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Viral rhinitis | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Injury due to fall | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0003 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Strep throat | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Vulval abcess | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Telangiectasia | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Binge drinking | Psychiatric disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Benign ovarian tumor | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Fatigue | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Benign mass in right breast | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Photophobia | Eye disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Erythema | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Miliaria | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Autoimmune Disorder | Immune system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Syncope | Nervous system disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Tinea Pedis | Infections and infestations | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Swelling | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG00026 events12 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Pain | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG00013 events8 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Bruising | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0007 events5 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Mass | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0004 events4 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Oedema | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0007 events4 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Pruritus | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Discolouration | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Skin Discolouration | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Induration | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Implant Site Paraesthesia | General disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Post Inflammatory Pigmentation Change | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0001 events1 affected287 at risk
- EG0010 events0 affected46 at risk
|
| Skin Dryness | Skin and subcutaneous tissue disorders | MedDRA (23.0) | Non-systematic Assessment | | - EG0002 events2 affected287 at risk
- EG0010 events0 affected46 at risk
|